Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Magn Reson Med. 2012 Jun 12;69(5):1443–1450. doi: 10.1002/mrm.24355

Figure 1.

Figure 1

Daily administration of 3-BP delayed SCC tumor growth. When tumor size became 1.0-1.2 cm (10 days after implantation), 10 mg/kg/day of glycolysis inhibitor 3-BP was intraperitoneally injected into mice bearing SCC tumor on their right leg. The 3-BP significantly suppressed the SCC tumor growth compared to control group of mice treated by PBS as vehicle.